Background: Topiramate (TPM) has the potential to become one of the most prominent
treatment options for alcohol use disorder (AUD). We investigated the efficacy of TPM for AUD …

Purpose To compare the efficacy and safety of non-benzodiazepines (non-BZDs) to
benzodiazepines (BZDs) in the treatment of alcohol withdrawal syndrome (AWS). Methods For …

Purpose Examine SSRIs’ efficacy in treating depression, anxiety, PTSD, and substance use
in individuals with addiction. Methods From their inception until August 6, 2021, we …

Background Demand for treatments for severe opioid use disorder is increasing worldwide.
The current pharmacotherapy is mainly focused on opioid and adrenergic receptors. The N-…

Background and Objectives Treating substance use disorder (SUD) in patients with co‐occurring
attention deficit hyperactivity disorder (ADHD) and SUD may lower medical, psychiatric, …

Background Long-term benzodiazepine (BZD) use may lead to dependence, addiction, and
neuropsychiatric disturbances. BZD discontinuation can cause severe withdrawal symptoms …

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual
response variability may be partially explained by genetic variation. Here we perform a …

Microfluidic technologies have emerged recently as a promising new route for the fabrication
of uniform emulsions. In this paper, we review microfluidic methods for synthesizing uniform …

… 79.2 G 9.3, p Z 0.001) and more frequent overall GI symptoms (KGSRS, 70.4 G 10.4 vs. 83.2
G 9.6, p Z 0.000). The patients with ERD showed similar symptom scores compared to those …

We would also like to extend our appreciation to this year’s invited speakers, who are both
outstanding leaders in their respective fields: Julie Dorsey, Massachusetts Institute of …